China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 30.97
(1.44%)
CNY 30.97
(1.44%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 22.14 Million CNY | 113.58% |
| 2022 | 10.36 Million CNY | -69.0% |
| 2021 | 33.44 Million CNY | -39.19% |
| 2020 | 55 Million CNY | -79.55% |
| 2019 | 269 Million CNY | -40.22% |
| 2018 | 450 Million CNY | 0.0% |
| 2017 | 450 Million CNY | 1932.06% |
| 2016 | 22.14 Million CNY | 0.0% |
| 2015 | 22.14 Million CNY | 0.0% |
| 2014 | - CNY | 100.0% |
| 2013 | -3.65 Million CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 40 Million CNY | 0.0% |
| 2010 | 40 Million CNY | -58.55% |
| 2009 | 96.5 Million CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q2 | 3.9 Million CNY | -100.0% |
| 2024 Q1 | 23.54 Million CNY | 0.0% |
| 2023 Q4 | 22.14 Million CNY | -6.81% |
| 2023 FY | 22.14 Million CNY | 113.58% |
| 2023 Q1 | 9.75 Million CNY | -5.9% |
| 2023 Q2 | 31.15 Million CNY | 219.33% |
| 2023 Q3 | 23.76 Million CNY | -23.73% |
| 2022 FY | 10.36 Million CNY | -69.0% |
| 2022 Q1 | 10.84 Million CNY | -67.58% |
| 2022 Q2 | 11.15 Million CNY | 2.93% |
| 2022 Q3 | 11.88 Million CNY | 6.48% |
| 2022 Q4 | 10.36 Million CNY | -12.74% |
| 2021 Q3 | 32.89 Million CNY | -1.08% |
| 2021 Q2 | 33.25 Million CNY | 321.6% |
| 2021 FY | 33.44 Million CNY | -39.19% |
| 2021 Q1 | 7.88 Million CNY | -85.66% |
| 2021 Q4 | 33.44 Million CNY | 1.67% |
| 2020 Q2 | 140 Million CNY | -47.96% |
| 2020 Q1 | 269 Million CNY | 0.0% |
| 2020 FY | 55 Million CNY | -79.55% |
| 2020 Q3 | 140 Million CNY | 0.0% |
| 2020 Q4 | 55 Million CNY | -60.71% |
| 2019 Q1 | 373 Million CNY | -17.11% |
| 2019 Q3 | 332.5 Million CNY | 3.1% |
| 2019 Q4 | 269 Million CNY | -19.1% |
| 2019 FY | 269 Million CNY | -40.22% |
| 2019 Q2 | 322.5 Million CNY | -13.54% |
| 2018 Q3 | 610 Million CNY | 0.0% |
| 2018 FY | 450 Million CNY | 0.0% |
| 2018 Q2 | 610 Million CNY | 10.91% |
| 2018 Q1 | 550 Million CNY | 22.22% |
| 2018 Q4 | 450 Million CNY | -26.23% |
| 2017 Q4 | 450 Million CNY | 54.03% |
| 2017 Q3 | 292.14 Million CNY | 0.0% |
| 2017 Q1 | 292.14 Million CNY | 1219.24% |
| 2017 Q2 | 292.14 Million CNY | 0.0% |
| 2017 FY | 450 Million CNY | 1932.06% |
| 2016 Q4 | 22.14 Million CNY | 0.0% |
| 2016 Q2 | 22.14 Million CNY | 0.0% |
| 2016 FY | 22.14 Million CNY | 0.0% |
| 2016 Q1 | 22.14 Million CNY | 0.0% |
| 2016 Q3 | 22.14 Million CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 22.14 Million CNY | 0.0% |
| 2015 FY | 22.14 Million CNY | 0.0% |
| 2015 Q3 | 22.14 Million CNY | 0.0% |
| 2014 FY | - CNY | 100.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 100.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | -3.65 Million CNY | 0.0% |
| 2013 Q4 | -3.65 Million CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q1 | 40 Million CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 FY | 40 Million CNY | 0.0% |
| 2011 Q4 | 40 Million CNY | 0.0% |
| 2010 FY | 40 Million CNY | -58.55% |
| 2009 FY | 96.5 Million CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |